| __timestamp | Bausch Health Companies Inc. | MiMedx Group, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2026300000 | 90480000 |
| Thursday, January 1, 2015 | 2682700000 | 133384000 |
| Friday, January 1, 2016 | 2810000000 | 179997000 |
| Sunday, January 1, 2017 | 2582000000 | 220119000 |
| Monday, January 1, 2018 | 2473000000 | 258528000 |
| Tuesday, January 1, 2019 | 2554000000 | 198205000 |
| Wednesday, January 1, 2020 | 2367000000 | 181022000 |
| Friday, January 1, 2021 | 2624000000 | 198359000 |
| Saturday, January 1, 2022 | 2625000000 | 208789000 |
| Sunday, January 1, 2023 | 2917000000 | 211124000 |
Unlocking the unknown
In the competitive landscape of healthcare, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Bausch Health Companies Inc. and MiMedx Group, Inc. have taken different paths in this regard over the past decade.
From 2014 to 2023, Bausch Health's SG&A expenses have shown a steady increase, peaking in 2023 with a 44% rise from 2014. This trend reflects their expansive operational strategies, yet it raises questions about cost efficiency.
Conversely, MiMedx Group has maintained a more stable SG&A expense profile, with a modest 133% increase over the same period. This suggests a more controlled approach to cost management, potentially offering a competitive edge in financial sustainability.
In conclusion, while Bausch Health's aggressive spending might fuel growth, MiMedx's disciplined approach could prove advantageous in the long run.
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Bausch Health Companies Inc.
SG&A Efficiency Analysis: Comparing BeiGene, Ltd. and Bausch Health Companies Inc.
Insmed Incorporated or Bausch Health Companies Inc.: Who Manages SG&A Costs Better?
Ascendis Pharma A/S or Bausch Health Companies Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and MiMedx Group, Inc.
Grifols, S.A. vs Bausch Health Companies Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Ionis Pharmaceuticals, Inc. vs Bausch Health Companies Inc.
SG&A Efficiency Analysis: Comparing Opthea Limited and MiMedx Group, Inc.
Breaking Down SG&A Expenses: Ultragenyx Pharmaceutical Inc. vs MiMedx Group, Inc.
Who Optimizes SG&A Costs Better? Bausch Health Companies Inc. or Supernus Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing ImmunityBio, Inc. and MiMedx Group, Inc.
Comparing SG&A Expenses: Soleno Therapeutics, Inc. vs MiMedx Group, Inc. Trends and Insights